Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 11, 2023

Study Completion Date

December 11, 2023

Conditions
Temporal Lobe Epilepsy
Interventions
DEVICE

Visualase MRI-Guided Laser Ablation

All subjects will undergo MRI-guided laser ablation of the amygdala and hippocampus with the Visualase System.

Trial Locations (23)

10032

Columbia University Medical Center, New York

11021

Northwell Health, Great Neck

19107

Thomas Jefferson University, Philadelphia

21287

Johns Hopkins University, Baltimore

22903

University of Virginia, Charlottesville

27157

Wake Forest Baptist Health, Winston-Salem

30322

Emory University, Atlanta

33136

University of Miami, Miami

40202

University of Louisville Hospital, Louisville

43214

Ohio Health Research Institute, Columbus

46202

Indiana University, Indianapolis

48202

Henry Ford Health System, Detroit

55905

Mayo Clinic, Rochester

60637

University of Chicago, Chicago

77030

The University of Texas Health Science Center at Houston, Houston

80045

University of Colorado Anschutz Medical Campus, Aurora

92688

Hoag Memorial Hospital Presbyterian, Newport Beach

94143

University of California, San Francisco, San Francisco

94305

Stanford University, Palo Alto

97239

Oregon Health & University Science, Portland

98104

University of Washington Harborview, Seattle

03766

Dartmouth-Hitchcock Medical Center, Lebanon

08901

Rutgers University - Robert Wood Johnson Medical School, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedtronicNeuro

INDUSTRY

NCT02844465 - Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate) | Biotech Hunter | Biotech Hunter